Tuberculosis, multidrug-resistant
Clinical trials for Tuberculosis, multidrug-resistant explained in plain language.
Never miss a new study
Get alerted when new Tuberculosis, multidrug-resistant trials appear
Sign up with your email to follow new studies for Tuberculosis, multidrug-resistant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Drug-Resistant TB: shorter, safer treatment on the horizon?
Disease control Recruiting nowThis study tests whether a shorter treatment regimen (13-24 weeks) using a combination of drugs (bedaquiline, linezolid, pretomanid, and moxifloxacin) works as well as the standard longer treatment for people with a type of drug-resistant tuberculosis. About 400 adults with fluor…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase 2/3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC